Ceylon Hospitals PLC (COSE:CHL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Ceylon Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 10,979 | 9,751 | 9,153 | 7,905 | 7,841 | |
Revenue Growth (YoY) | 12.60% | 6.53% | 15.78% | 0.82% | 41.39% |
Cost of Revenue | 4,210 | 3,928 | 4,014 | 3,095 | 2,880 |
Gross Profit | 6,769 | 5,822 | 5,139 | 4,811 | 4,961 |
Selling, General & Admin | 4,427 | 3,674 | 3,302 | 2,878 | 2,854 |
Other Operating Expenses | 784.36 | 1,243 | 1,254 | 1,020 | 717.5 |
Operating Expenses | 5,211 | 4,917 | 4,556 | 3,898 | 3,571 |
Operating Income | 1,558 | 905.23 | 582.91 | 913.18 | 1,389 |
Interest Expense | -193.05 | -246.5 | -137.83 | -83.35 | -76.56 |
Interest & Investment Income | 37.24 | 51.14 | 99.66 | 207.25 | 81.82 |
Earnings From Equity Investments | - | - | - | - | 11.72 |
Currency Exchange Gain (Loss) | - | -0.72 | - | - | - |
Other Non Operating Income (Expenses) | - | -4.3 | -6.84 | -4.54 | -4.01 |
EBT Excluding Unusual Items | 1,402 | 704.85 | 537.9 | 1,033 | 1,402 |
Gain (Loss) on Sale of Investments | - | 216.97 | 113.44 | 27.8 | -32.92 |
Gain (Loss) on Sale of Assets | - | 36.1 | 6.43 | - | 5.2 |
Other Unusual Items | - | - | 1.11 | - | 14.45 |
Pretax Income | 1,402 | 957.92 | 658.89 | 1,060 | 1,389 |
Income Tax Expense | 350.39 | 231.91 | 205.07 | 408.65 | 279.38 |
Earnings From Continuing Operations | 1,052 | 726.01 | 453.81 | 651.67 | 1,110 |
Minority Interest in Earnings | -100.66 | -73.41 | -36.62 | -79.84 | -127.2 |
Net Income | 951.15 | 652.6 | 417.19 | 571.83 | 982.32 |
Net Income to Common | 951.15 | 652.6 | 417.19 | 571.83 | 982.32 |
Net Income Growth | 45.75% | 56.43% | -27.04% | -41.79% | 75.31% |
Shares Outstanding (Basic) | 167 | 159 | 144 | 136 | 135 |
Shares Outstanding (Diluted) | 167 | 159 | 144 | 136 | 135 |
Shares Change (YoY) | 5.05% | 10.73% | 6.23% | 0.02% | - |
EPS (Basic) | 5.68 | 4.09 | 2.90 | 4.22 | 7.25 |
EPS (Diluted) | 5.68 | 4.09 | 2.90 | 4.22 | 7.25 |
EPS Growth | 38.75% | 41.26% | -31.32% | -41.80% | 75.31% |
Free Cash Flow | 919.56 | 843.18 | -60.01 | -2,110 | 395.27 |
Free Cash Flow Per Share | 5.49 | 5.29 | -0.42 | -15.57 | 2.92 |
Dividend Per Share | - | 1.000 | 0.500 | 0.575 | 1.250 |
Dividend Growth | - | 100.00% | -13.04% | -54.00% | 56.25% |
Gross Margin | 61.65% | 59.71% | 56.14% | 60.86% | 63.27% |
Operating Margin | 14.19% | 9.28% | 6.37% | 11.55% | 17.72% |
Profit Margin | 8.66% | 6.69% | 4.56% | 7.23% | 12.53% |
Free Cash Flow Margin | 8.38% | 8.65% | -0.66% | -26.70% | 5.04% |
EBITDA | 2,242 | 1,416 | 1,025 | 1,302 | 1,729 |
EBITDA Margin | 20.42% | 14.53% | 11.20% | 16.48% | 22.05% |
D&A For EBITDA | 683.86 | 511.15 | 442.58 | 389.26 | 339.85 |
EBIT | 1,558 | 905.23 | 582.91 | 913.18 | 1,389 |
EBIT Margin | 14.19% | 9.28% | 6.37% | 11.55% | 17.72% |
Effective Tax Rate | 24.99% | 24.21% | 31.12% | 38.54% | 20.11% |